Clinical Trial Update: A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating preventive treatments for GPRC5D-related oral events in patients with multiple myeloma, and the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING